Voronoi, Inc. Logo

Voronoi, Inc.

Develops selective kinase inhibitors and targeted protein degraders for precision oncology.

310210 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 에스동 18층, 연수구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Voronoi, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel therapeutics, with a primary focus on precision medicine for oncology. The company's expertise lies in creating innovative kinase inhibitors and targeted protein degraders. Voronoi leverages its proprietary drug discovery platform, VORONOMICS™, to rapidly identify and optimize drug candidates. This platform is designed to develop therapies with high selectivity and the ability to penetrate the brain barrier. Its pipeline includes targeted treatments for various cancers, such as non-small cell lung cancer (NSCLC) and HER2-positive solid tumors, aiming to accelerate the delivery of new therapies from design to the clinic.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Voronoi, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-18 00:00
M&A Activity
투자판단관련주요경영사항 (VRN04 프로그램 연구에 대한 옵션 행사 및 자산 구매 계약 체결)
Korean 10.7 KB
2025-09-08 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 125.2 KB
2025-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 121.8 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 120.3 KB

Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea 115180
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan 6098
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889

Talk to a Data Expert

Have a question? We'll get back to you promptly.